If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Directorate Change

12 Dec 2011 07:00

RNS Number : 7431T
Microsaic Systems plc
12 December 2011
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Trading update and directorate change

 

 

12th December 2011: Microsaic Systems plc (AIM: MSYS), a leading developer of chip-based scientific instruments today announces a directorate change and an update on trading.

The Company announces that Alan Finlay, CEO, has stepped down from the Board with immediate effect. Current Chairman Eric Yeatman has taken the post of acting CEO while the board identifies a suitable replacement. Colin Nicholl, the Company's Deputy Chairman, will serve as Chairman during this period. Alan will remain in the Company to advise and assist the Board during the transitional phase.

Since Microsaic Systems published its half year results on 26th September, the Company has continued to progress the commercialisation of its innovative chip-based mass spectrometry system - the Microsaic 3500 MiD - and has achieved notable success: as stated in September, relationships have been established with five potential OEM sales channels, with one unit being shipped. Since then a unit has been shipped to a second partner and it has received a positive initial technical evaluation. In addition, a major Asian instrumentation company has expressed interest in becoming an OEM - our 6th to-date; and Microsaic has delivered a 3500 MiD to a major European technical research organisation as part of its on-going European Commission-supported collaboration to develop a system for monitoring industrial bio-processes.

The implementation of the direct sales strategy is also going well. Since the delivery of a first system to a major international pharmaceutical company, which was reported in September, the Company has now received further orders for trial systems from two more international pharmaceutical clients.

Commenting on the news, Microsaic Acting CEO Eric Yeatman said:

"We are delighted to be updating the market with the news that our strategy is being validated by customers and partners. The attraction and uniqueness of our miniature chip-based mass spectrometry products is being recognised and our growing sales pipeline gives us confidence for the future.

The Board would like to take this opportunity to thank Alan for his very significant contribution to the development of the Company since joining over ten years ago, and recognises his vision, drive and hard work during his tenure as CEO."

Contacts

 

Microsaic Systems

Eric Yeatman, Acting CEO

 

Via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

Citigate Dewe Rogerson

Ginny Pulbrook, Chris Gardner, Mark Swallow

 

+44 (0)20 7282 2995/2948

+44 (0)7903 737703

 

 

About Microsaic Systems

 

Microsaic Systems develops micro-engineered scientific instruments for the identification of chemicals in liquids, gases and solids. Microsaic's technologies are based on the gold-standard technique of mass spectrometry (MS), which is currently based on large and expensive systems.

 

Microsaic is the first and only company to have successfully miniaturised MS onto patented chip-based technologies (ionchip®, spraychip® and vac-chip®) to create instruments that retain the speed and sensitivity of MS but are smaller, lighter, more energy efficient and cheaper to run than conventional MS systems.

 

MS technology is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London and was admitted to AIM in April 2011 under the ticker MSYS.

 

www.microsaic.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFFLFFFLFLFBX
Date   Source Headline
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.